Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis.

about

Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis.

Item

http://www.wikidata.org/entity/Q35884646

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@ast

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@en

type

Item

label

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@ast

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@en

prefLabel

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@ast

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@en

P1476

Calcitonin gene-related peptid ...... of migraine: a meta-analysis.

@en

P2093

Peiwei Hong

http://www.w3.org/2001/XMLSchema#string

Yao Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Serotonin and CGRP in migraine

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Calcitonin gene-related peptide: physiology and pathophysiology

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds.

Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study.

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

CGRP receptor antagonism and migraine therapy.

BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.

P304

20-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.3109/00207454.2015.1137915

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26728923

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder